Acute amphotericin B overdose

被引:16
作者
Burke, Douglas [1 ]
Lal, Rajiv [1 ]
Finkel, Kevin W. [1 ]
Samuels, Joshua [1 ]
Foringer, John R. [1 ]
机构
[1] Univ Texas, Sch Med, Div Renal Dis & Hypertens, Houston, TX 77030 USA
关键词
amphotericin B; toxicity;
D O I
10.1345/aph.1H157
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
OBJECTIVE: To report the clinical course of a woman with cryptococcal meningitis and no previous cardiac disease who developed a fatal cardiac arrhythmia after an acute overdose of amphotericin B and to review its toxicity. CASE SUMMARY: A 41-year-old woman with a history of proliferative glomerulonephritis from systemic lupus erythematosus was admitted with a diagnosis of cryptococcal meningitis. Liposomal amphotericin B was prescribed at the standard dose of 5 mg/kg/day; however, amphotericin B deoxycholate 5 mg/kg was inadvertently administered (usual dose of the deoxycholate formulation is 0.5-0.8 mg/kg/day). The patient developed cardiac arrhythmias, acute renal failure, and anemia. The medication error was noticed after she had received 2 doses of amphotericin B deoxycholate, and it was then discontinued. Despite treatment in the intensive care unit, the woman died on the sixth day after admission. DISCUSSION: Amphotericin B deoxycholate has been reported to produce significant cardiac toxicity, with ventricular arrhythmias and bradycardia reported in overdoses in children and in adults with preexisting cardiac disease, even when administered in conventional dosages and infusion rates. Use of the Naranjo probability scale indicated a highly probable relationship between the observed cardiac toxicity and amphotericin B deoxycholate therapy in this patient. CONCLUSIONS: Given the fulminant course of amphotericin B deoxycholate overdosage and lack of effective therapy, stringent safeguards against its improper administration should be in place.
引用
收藏
页码:2254 / 2259
页数:6
相关论文
共 24 条
[1]   VENTRICULAR ARRHYTHMIAS WITH CONVENTIONAL AND LIPOSOMAL AMPHOTERICIN [J].
AGUADO, JM ;
HIDALGO, M ;
MOYA, I ;
ALCAZAR, JM ;
JIMENEZ, MJ ;
NORIEGA, AR .
LANCET, 1993, 342 (8881) :1239-1239
[2]  
BROOKS D, 1991, J PHARMACOL EXP THER, V3, P1243
[3]  
BUTLER WT, 1964, P SOC EXP BIOL MED, V116, P857, DOI 10.3181/00379727-116-29391
[4]   AMPHOTERICIN-B NEPHROTOXICITY - INCREASED RENAL RESISTANCE AND TUBULE PERMEABILITY [J].
CHENG, JT ;
WITTY, RT ;
ROBINSON, RR ;
YARGER, WE .
KIDNEY INTERNATIONAL, 1982, 22 (06) :626-633
[5]  
CHUNG DK, 1971, AM REV RESPIR DIS, V103, P831
[6]   AMPHOTERICIN-B OVERDOSE IN PEDIATRIC-PATIENTS WITH ASSOCIATED CARDIAC-ARREST [J].
CLEARY, JD ;
HAYMAN, J ;
SHERWOOD, J ;
LASALA, GP ;
PIAZZAHEPP, T .
ANNALS OF PHARMACOTHERAPY, 1993, 27 (06) :715-719
[7]   TRANSIENT ASYSTOLE ASSOCIATED WITH AMPHOTERICIN-B INFUSION [J].
DEMONACO, HJ ;
MCGOVERN, B .
DRUG INTELLIGENCE & CLINICAL PHARMACY, 1983, 17 (7-8) :547-548
[8]  
Gussak HM, 2001, AM J KIDNEY DIS, V37, part. no.
[9]  
HALPERN SE, 1970, P SOC EXP BIOL MED, V134, P1073, DOI 10.3181/00379727-134-34947
[10]  
HEARD H, 1960, AM REV RESPIR DIS, V81, P43